Business Segment Information (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Segment Reporting Information, by Segment [Table Text Block]

(In millions)			2012		2011		2010

Revenues
	Analytical Technologies		$	4,123.7	$	3,845.4	$	3,238.2
	Specialty Diagnostics			2,962.3		2,469.9		2,149.0
	Laboratory Products and Services			5,990.0		5,762.9		5,473.0
	Eliminations			(566.1)		(519.4)		(467.1)

		Consolidated revenues		12,509.9		11,558.8		10,393.1

Segment Income
	Analytical Technologies (a)			772.7		720.0		550.1
	Specialty Diagnostics (a)			761.2		598.4		487.9
	Laboratory Products and Services (a)			846.0		810.9		781.2

		Subtotal reportable segments (a)		2,379.9		2,129.3		1,819.2

	Cost of revenues charges			(55.6)		(72.6)		(13.2)
	Selling, general and administrative charges, net			(12.5)		(61.5)		(3.0)
	Restructuring and other costs, net			(82.1)		(96.5)		(60.2)
	Amortization of acquisition-related intangible assets			(747.6)		(647.9)		(554.7)

		Consolidated operating income		1,482.1		1,250.8		1,188.1
	Other expense, net (b)			(212.7)		(118.0)		(100.4)

	Income from continuing operations before income taxes		$	1,269.4	$	1,132.8	$	1,087.7

Depreciation
	Analytical Technologies		$	65.3	$	61.0	$	54.6
	Specialty Diagnostics			73.0		50.1		37.3
	Laboratory Products and Services			97.8		100.6		93.1

		Consolidated depreciation	$	236.1	$	211.7	$	185.0

(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.

(b)	The company does not allocate other expense, net to its segments.


(In millions)			2012		2011		2010

Total Assets
	Analytical Technologies		$	5,854.7	$	6,262.8	$	4,266.4
	Specialty Diagnostics			9,841.0		8,319.6		4,575.9
	Laboratory Products and Services			11,097.3		10,713.9		10,768.1
	Corporate/Other (c)			651.6		1,537.4		1,739.0

		Consolidated total assets	$	27,444.6	$	26,833.7	$	21,349.4

Capital Expenditures
	Analytical Technologies		$	77.0	$	71.3	$	45.6
	Specialty Diagnostics			97.6		63.2		51.0
	Laboratory Products and Services			104.5		113.9		123.4
	Corporate/Other			36.0		12.5		25.4

		Consolidated capital expenditures	$	315.1	$	260.9	$	245.4

(c)	Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices and assets of the discontinued operations.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

(In millions)			2012		2011		2010

Revenues
	Analytical Technologies		$	4,123.7	$	3,845.4	$	3,238.2
	Specialty Diagnostics			2,962.3		2,469.9		2,149.0
	Laboratory Products and Services			5,990.0		5,762.9		5,473.0
	Eliminations			(566.1)		(519.4)		(467.1)

		Consolidated revenues		12,509.9		11,558.8		10,393.1

Segment Income
	Analytical Technologies (a)			772.7		720.0		550.1
	Specialty Diagnostics (a)			761.2		598.4		487.9
	Laboratory Products and Services (a)			846.0		810.9		781.2

		Subtotal reportable segments (a)		2,379.9		2,129.3		1,819.2

	Cost of revenues charges			(55.6)		(72.6)		(13.2)
	Selling, general and administrative charges, net			(12.5)		(61.5)		(3.0)
	Restructuring and other costs, net			(82.1)		(96.5)		(60.2)
	Amortization of acquisition-related intangible assets			(747.6)		(647.9)		(554.7)

		Consolidated operating income		1,482.1		1,250.8		1,188.1
	Other expense, net (b)			(212.7)		(118.0)		(100.4)

	Income from continuing operations before income taxes		$	1,269.4	$	1,132.8	$	1,087.7

Depreciation
	Analytical Technologies		$	65.3	$	61.0	$	54.6
	Specialty Diagnostics			73.0		50.1		37.3
	Laboratory Products and Services			97.8		100.6		93.1

		Consolidated depreciation	$	236.1	$	211.7	$	185.0

(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.

(b)	The company does not allocate other expense, net to its segments.

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]


(In millions)		2012		2011		2010

Revenues (d)
	United States	$	6,424.4	$	6,023.9	$	5,806.8
	China		735.8		559.6		405.3
	Germany		681.5		698.3		592.9
	United Kingdom		507.1		472.3		409.6
	Other		4,161.1		3,804.7		3,178.5

		$	12,509.9	$	11,558.8	$	10,393.1

Long-lived Assets (e)
	United States	$	862.4	$	797.9	$	708.5
	United Kingdom		223.9		209.2		170.4
	Germany		165.2		158.6		121.7
	Other		474.9		445.6		319.3

		$	1,726.4	$	1,611.3	$	1,319.9

(d)	Revenues are attributed to countries based on customer location.
(e)	Includes property, plant and equipment, net.

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations.

+ References+ Details

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References+ Details

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details